PURPOSE: Pain, fatigue, dyspnea, and distress are commonly reported cancer-related symptoms, but few studies have examined the effects of multiple concurrent symptoms in longer-term cancer survivors. We examined the impact of varying degrees of symptom burden on health-related quality of life (HRQOL) and performance status in surgically treated non-small cell lung cancer (NSCLC) survivors. METHODS: A sample of 183 NSCLC survivors 1-6 years post-surgical treatment completed questionnaires assessing five specific symptoms (pain, fatigue, dyspnea, depression, and anxiety), HRQOL, and performance status. The number of concurrent clinically significant symptoms was calculated as an indicator of symptom burden. RESULTS: Most survivors (79.8 %) had some degree of symptom burden, with 30.6 % reporting one clinically significant symptom, 27.9 % reporting two symptoms, and 21.3 % reporting three or more symptoms. Physical HRQOL significantly decreased as the degree of symptom burden increased, but mental HRQOL was only significantly decreased in those with three or more symptoms. Receiver-operating characteristic (ROC) curves showed that having multiple concurrent symptoms (two or more) was most likely associated with limitations in functioning (area under a ROC curve = 0.75, sensitivity = 0.81, specificity = 0.54). CONCLUSIONS: Two or more clinically significant symptoms are identified as the "tipping point" for showing adverse effects on HRQOL and functioning. This highlights the need for incorporating multiple-symptom assessment into routine clinical practice. Comprehensive symptom management remains an important target of intervention for improved post-treatment HRQOL and functioning among lung cancer survivors.
PURPOSE:Pain, fatigue, dyspnea, and distress are commonly reported cancer-related symptoms, but few studies have examined the effects of multiple concurrent symptoms in longer-term cancer survivors. We examined the impact of varying degrees of symptom burden on health-related quality of life (HRQOL) and performance status in surgically treated non-small cell lung cancer (NSCLC) survivors. METHODS: A sample of 183 NSCLC survivors 1-6 years post-surgical treatment completed questionnaires assessing five specific symptoms (pain, fatigue, dyspnea, depression, and anxiety), HRQOL, and performance status. The number of concurrent clinically significant symptoms was calculated as an indicator of symptom burden. RESULTS: Most survivors (79.8 %) had some degree of symptom burden, with 30.6 % reporting one clinically significant symptom, 27.9 % reporting two symptoms, and 21.3 % reporting three or more symptoms. Physical HRQOL significantly decreased as the degree of symptom burden increased, but mental HRQOL was only significantly decreased in those with three or more symptoms. Receiver-operating characteristic (ROC) curves showed that having multiple concurrent symptoms (two or more) was most likely associated with limitations in functioning (area under a ROC curve = 0.75, sensitivity = 0.81, specificity = 0.54). CONCLUSIONS: Two or more clinically significant symptoms are identified as the "tipping point" for showing adverse effects on HRQOL and functioning. This highlights the need for incorporating multiple-symptom assessment into routine clinical practice. Comprehensive symptom management remains an important target of intervention for improved post-treatment HRQOL and functioning among lung cancer survivors.
Authors: Christine Miaskowski; Bruce A Cooper; Steven M Paul; Marylin Dodd; Kathryn Lee; Bradley E Aouizerat; Claudia West; Maria Cho; Alice Bank Journal: Oncol Nurs Forum Date: 2006-09-01 Impact factor: 2.172
Authors: Andrea L Cheville; Paul J Novotny; Jeffrey A Sloan; Jeffrey R Basford; Jason A Wampfler; Yolanda I Garces; Aminah Jatoi; Ping Yang Journal: J Pain Symptom Manage Date: 2011-03-12 Impact factor: 3.612
Authors: Karine A S L Ferreira; Miako Kimura; Manoel J Teixeira; Tito R Mendoza; Jose Cláudio M da Nóbrega; Silvia R Graziani; Teresa Yae Takagaki Journal: J Pain Symptom Manage Date: 2008-03-24 Impact factor: 3.612
Authors: Virginia Sun; Betty Ferrell; Gloria Juarez; Lawrence D Wagman; Yun Yen; Vincent Chung Journal: Oncol Nurs Forum Date: 2008-05 Impact factor: 2.172
Authors: Thomas W LeBlanc; Myles Nickolich; Christel N Rushing; Gregory P Samsa; Susan C Locke; Amy P Abernethy Journal: Support Care Cancer Date: 2015-03-21 Impact factor: 3.603
Authors: Marta Linares-Moya; Janet Rodríguez-Torres; Alejandro Heredia-Ciuró; María Granados-Santiago; Laura López-López; Florencio Quero-Valenzuela; Marie Carmen Valenza Journal: Support Care Cancer Date: 2021-09-20 Impact factor: 3.359
Authors: Sumin Shin; Sunga Kong; Danbee Kang; Hong Kwan Kim; Hye Yun Park; Genehee Lee; Jong Ho Cho; Young Mog Shim; Juhee Cho Journal: Respir Res Date: 2022-08-30
Authors: Maja S Sommer; Karen Trier; Jette Vibe-Petersen; Karl B Christensen; Malene Missel; Merete Christensen; Klaus R Larsen; Seppo W Langer; Carsten Hendriksen; Paul F Clementsen; Jesper H Pedersen; Henning Langberg Journal: Integr Cancer Ther Date: 2016-10-03 Impact factor: 3.279